Search

A new program known as TeamBirth, launching at UT Southwestern Medical Center’s William P. Clements Jr. University Hospital in May, aims to improve communication among all the members of a patient’s care team – an approach that could improve patient-centered maternity care and boost childbirth outcomes.

Thyrotoxic periodic paralysis (TPP), a rare neurological condition causing limbs to go limp, may be an underrecognized cause of paralysis in young Hispanic men, a review of data by UT Southwestern endocrinologists shows.

With new cases of malaria being reported in Texas and Florida, researchers at UT Southwestern Medical Center continue to explore compounds for more effective drug-resistant therapies and biological targets to interfere with the parasites that spread the potentially fatal disease.

Myron Frederick Weiner, M.D., Professor Emeritus of Psychiatry at UT Southwestern Medical Center and a noted clinical researcher in geriatric psychiatry and Alzheimer’s disease, died July 17 in Dallas. He was 89.

The rate of heart attacks, strokes, and other cardiovascular complications increased among patients hospitalized with COVID-19 between March 2020 and December 2021, according to a new study led by UT Southwestern Medical Center researchers.

Patients with endometriosis are more likely to experience complications during and after hysterectomies, a study by UT Southwestern Medical Center researchers shows.

As a child in Beirut, Ahmad Anouti, M.D., endured dozens of medical procedures, hundreds of medications, and numerous setbacks before a liver transplant at age 16 saved his life.

Two classes of drugs prescribed off-label for some patients with Type 1 diabetes can provide significant benefits but also come with health concerns, according to a study by UT Southwestern Medical Center researchers.

Stem cell biologist Sean J. Morrison, Ph.D., has been elected by his peers as an associate member of the European Molecular Biology Organization (EMBO).

Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity.